HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A polymorphism in the microsomal triglyceride transfer protein can predict the response to antiviral therapy in Egyptian patients with chronic hepatitis C virus genotype 4 infection.

AbstractBACKGROUND/AIMS:
A polymorphism in the microsomal triglyceride transfer protein (MTP) is associated with hepatic fibrosis, and carriers showed higher levels of steatosis, higher levels of hepatitis C virus (HCV) RNA and advanced fibrosis. The aim of this study was to study MTP expression pattern in HCV patients and impact of the MTP polymorphism on the response to antiviral therapy.
METHODS:
One hundred consecutive naive HCV genotype 4 patients were recruited to receive antiviral therapy, and 40 control subjects were also recruited. Demographic, laboratory, and histopathology data were collected. DNA was isolated, and the samples were subjected to polymerase chain reaction analysis and genotyping for MTP by restriction fragment length polymorphism analysis.
RESULTS:
Patients and controls were age- and sex-matched (male/female, 56/44, age, 39.2±7.8 years for patients with HCV; male/female, 18/22, age, 38.1±8.1 years for controls). MTP single nucleotide polymorphisms (SNPs) (GG, GT, TT) and alleles (G, T) in the patients versus the controls were 70%, 21%, 9% & 80.5%, 19.5% versus 10%, 87.5%, 2.5% & 53.8%, 46.3%, respectively (p=0.0001). The sustained viral response (SVR) of the patients was 60%. SNPs in MTP genotypes (GG, GT, and TT) and alleles (G and T) in the responders and nonresponders were 71.7%, 25%, 3.3% & 84.2%, 15.8% versus 67.5%, 15%, 17.5% & 75%, 25% (p=0.038 and p=0.109, respectively). A multivariate analysis showed that the GT genotype was an independent predictor of SVR (area under the curve 90% and p=0.0001).
CONCLUSIONS:
MTP could be a new predictor for SVR to antiviral therapy in patients with HCV genotype 4 infection.
AuthorsYasmin Saad, Olfat Shaker, Yasser Nassar, Lama Ahmad, Mohamed Said, Gamal Esmat
JournalGut and liver (Gut Liver) Vol. 8 Issue 6 Pg. 655-61 (Nov 2014) ISSN: 2005-1212 [Electronic] Korea (South)
PMID25287167 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Carrier Proteins
  • RNA, Viral
  • microsomal triglyceride transfer protein
Topics
  • Adult
  • Antiviral Agents (therapeutic use)
  • Carrier Proteins (genetics)
  • Case-Control Studies
  • Egypt
  • Female
  • Genotype
  • Hepacivirus (genetics)
  • Hepatitis C, Chronic (drug therapy, genetics)
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide
  • RNA, Viral (blood)
  • Treatment Outcome
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: